logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Astec Lifesciences Ltd

Astec Lifesciences

Small Cap•606 Employees•IPO 2009
Current Price
₹628.25
4.55 (0.73%)Updated
NSE :ASTEC
BSE :533138
Sector :Chemicals
Today's Range
₹615.95
₹628.25
union icon
₹649.00
52 Week Range
52W Low₹554.00
52W High₹998.40
₹628.25
union icon
Downside13.40%
Upside58.92%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹1,431.04 Cr
Market Cap
Total market value of company
P/E Ratio
-
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
4.88
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹-43.25
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
-12.49%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
-12.90%
ROCE
Return on Capital Employed. >15% is good
Net Margin
-21.82%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
-2.42%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
-25.20%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
36.60%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
2.36
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹118.79
Book Value
Net asset value per share
Dividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
72.40%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

4 points
  • •Robust 72.42% promoter holding signals strong insider confidence and stability.
  • •Diversified product portfolio includes fungicides, herbicides, insecticides, and specialty chemicals.

Weaknesses

5 points
  • •Reported substantial quarterly net loss of -24.4 Cr, indicating operational challenges.
  • •Negative ROE -45.3% and ROCE -12.9% highlight severe profitability issues.

Opportunities

2 points
  • •Consistent demand in Pesticides & Agrochemicals industry offers inherent stability.
  • •Quarterly profit variation improved by 36.60%, hinting at efficiency gains.

Threats

5 points
  • •Intense competition from profitable peers like PI Industries challenges market share.
  • •Significant decline in FII and DII holdings indicates loss of institutional confidence.

Segment-wise Financial Analysis

Financial Results

Balance Sheet

Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format

No Balance Sheet Data Available

Standalone annual data is not available for this symbol.
Try switching to Consolidated view.

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
Tanya Dubash
01 Jan 202502 Jan 20251.35 L
1.35 L
₹1,094.96BUY
Pirojsha Godrej
01 Jan 202502 Jan 20251.35 L
1.35 L
₹1,094.96BUY
Nisaba Godrej
01 Jan 202502 Jan 20251.35 L
1.35 L
₹1,094.96BUY
Nadir Godrej
01 Jan 202502 Jan 20254.05 L
4.05 L
₹1,094.96BUY

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹712.28+₹84.03+13.38%
R3₹679.23+₹50.98+8.12%
R2₹664.12+₹35.87+5.71%
R1₹646.18+₹17.93+2.85%
PIVOT₹631.072.820.45%
CURRENT₹628.25--
S1₹547.03-₹81.22-12.93%
S2₹580.08-₹48.17-7.67%
S3₹598.02-₹30.23-4.81%
S4₹613.13-₹15.12-2.41%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.57L
(02 Mar 2026)
-47.5% vs avg
Delivery %
29.0%
(02 Mar 2026)
-3.8% vs avg
Avg Volume (20D)
1.08L
(03 Feb - 02 Mar)
20-day average
Avg Delivery %
32.8%
(03 Feb - 02 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Coromandel International Ltd
69,969.95 ₹ Cr
Best Profit Growth
Zuari Agro Chemicals Ltd
981.00 %
Highest Dividend Yield
Southern Petrochemicals Industries Corporation Ltd
5.00 %

Peer Comparison

Company Name
ADVANCE
BESTAGRO
Best Agrolife Ltd
BHAGCHEM
Bhagiradha Chemicals & Industries Ltd
BHARATRAS
Bharat Rasayan Ltd
COROMANDEL
Coromandel International Ltd
DHARMAJ
Dharmaj Crop Guard Ltd
EXCELINDUS
Excel Industries Ltd
HERANBA
Heranba Industries Ltd
INSECTICID
Insecticides India Ltd
IPL
India Pesticides Ltd
KHAICHEM
Khaitan Chemicals & Fertilizers Ltd
KRISHANA
Krishana Phoschem Ltd
MADRASFERT
Madras Fertilizers Ltd
MOL
Meghmani Organics Ltd
SPIC
Southern Petrochemicals Industries Corporation Ltd
ZUARI
Zuari Agro Chemicals Ltd

About

ASTEC

Astec Lifesciences Ltd

Astec LifeSciences Limited is a prominent Indian company specializing in the manufacturing and distribution of agrochemical active ingredients and pharmaceutical intermediates. Its primary focus lies within the agrochemical sector, providing a diverse range of products designed to enhance agricultural yields and protect crops from various diseases and pests. A significant portion of their business involves the production and sale of triazole fungicides, utilized extensively in treating field crops against a variety of fungal infections.

The company's fungicide offerings are tailored to address specific crop needs. They provide foliar treatments to combat diseases such as scab, powdery mildew, shot-hole, blossom blight, and rust. Furthermore, Astec LifeSciences supplies seed treatments for crops like cotton, maize, barley, rice, and wheat, safeguarding seeds and soil from various pathogens. Their product range even extends to post-harvest treatments, ensuring crop preservation throughout the entire agricultural cycle. Beyond fungicides, they also produce and market a selection of herbicides and insecticides, catering to a broader spectrum of crop protection needs.

Beyond the core agricultural market, Astec LifeSciences also produces specialty chemicals. This diversification allows the company to tap into different industries, further enhancing its revenue streams. The incorporation of a food additive and wood preservative product line suggests a strategic expansion aimed at leveraging their chemical expertise into related sectors. This diversification strategy mitigates reliance on any single product category and contributes to the company's overall financial stability.

A key aspect of Astec LifeSciences' business strategy is its commitment to export markets. The company actively engages in international trade, supplying its products to global customers. This international presence positions Astec LifeSciences as a key player in the broader agrochemical market, enhancing its visibility and generating additional revenue streams. Established in 1994 and headquartered in Mumbai, India, Astec LifeSciences Limited operates as a subsidiary of Godrej Agrovet Limited, benefiting from the larger parent company's resources and market expertise.

COMPANY FACTS - ASTEC

Registered Address

Godrej One, 3rd Floor, Pirojshanagar,, Eastern Express Highway, Vikhroli (East)

Mumbai

MAHARASHTRA

IN

Tel: 912225188010

Website:https://www.astecls.com/

Investor Relations:http://www.astecls.com/investors.aspx
Company Details

Group: Materials

Sector: Materials

Industry: Chemicals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 606

IPO Date: 25/11/2009

MANAGEMENT - ASTEC

Mr. Nadir Godrej

Non-Executive Chairman of the Board

Ms. Mugdha Khare

Chief Financial Officer

Ms. Tejashree Pradhan

Compliance Officer, Company Secretary

Mr. Burjis Godrej

Non-Executive Non-Independent Director

Mr. Ashok Hiremath

Non-Executive Non-Independent Director

Mr. Balram Yadav

Non-Executive Non-Independent Director

Mr. Nandkumar Dhekne

Non-Executive Independent Director

Mr. Rishinaradamangalam Govindan

Non-Executive Independent Director

Ms. Anjali Gupte

Non-Executive Independent Director

Mr. Vijay Khot

Non-Executive Independent Director

Prof. Dr. Ganapati Yadav

Non-Executive Independent Director

Investor Questions Answered

Astec Lifesciences Ltd (ASTEC) Stock FAQs

Get answers to the most common questions about Astec Lifesciences Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Astec Lifesciences Ltd (ASTEC) is ₹628.25. Today, the stock has gained by ₹4.55 (0.73%), trading in a range of ₹615.95 to ₹649. The stock opened at ₹616 with a trading volume of 56,563 shares.
Astec Lifesciences Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,431.04 crores, P/E ratio of 0.00, ROE of -12.49%, and ROCE of -12.90%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Astec Lifesciences Ltd (ASTEC) is ₹998.4, while the 52-week low is ₹554. Currently trading at ₹628.25, the stock is 16.7% away from its 52-week low and 37.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Astec Lifesciences Ltd stock at ₹628.25 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of N/A. Today's performance shows a gain of 0.73%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Astec Lifesciences Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹628.25, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Astec Lifesciences Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: N/A, ROE: -12.49%, ROCE: -12.90%, Dividend Yield: 0.00%, EPS: ₹-43.25, Book Value: ₹118.79, Debt-to-Equity: 2.36, and Current Ratio: N/A. The company's market cap stands at ₹1,431.04 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Astec Lifesciences Ltd stock opened at ₹616 and is currently trading at ₹628.25, showing a gain of ₹4.55 (0.73%). The intraday high is ₹649 and low is ₹615.95. The trading volume stands at 56,563 shares, indicating moderate market participation today.
Astec Lifesciences Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-43.25, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
Astec Lifesciences Ltd has a market capitalization of ₹1,431.04 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹628.25) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Astec Lifesciences Ltd has a book value of ₹118.79 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹628.25, which is 428.9% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Astec Lifesciences Ltd has a Return on Equity (ROE) of -12.49% and Return on Capital Employed (ROCE) of -12.90%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Astec Lifesciences Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Astec Lifesciences Ltd has a debt-to-equity ratio of 2.36, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 2 indicates high leverage and potentially higher financial risk. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Astec Lifesciences Ltd has an Earnings Per Share (EPS) of ₹-43.25, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹628.25 and P/E ratio of 0.00, investors are paying 0.00 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Astec Lifesciences Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Astec Lifesciences Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Astec Lifesciences Ltd stock, consider: 1) Fundamental Analysis - Review P/E (0.00), ROE (-12.49%), debt-to-equity (2.36), and growth rates. 2) Technical Analysis - Check 52-week range (₹554.00 - ₹998.40), moving averages, and chart patterns. 3) Valuation - Compare current price (₹628.25) with book value (₹118.79) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Astec Lifesciences Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹628.25 is 6183x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Astec Lifesciences Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹554.00 - ₹998.40). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 2.36 indicates leverage. 4) Liquidity Risk - Based on trading volume of 56,563 shares. 5) Valuation Risk - P/E of 0.00 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Astec Lifesciences Ltd operates in the industry with key metrics: P/E ratio of 0.00, ROE of -12.49%, market cap of ₹1,431.04 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 2.36), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Astec Lifesciences Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹628.25, with a 52-week range of ₹554.00 to ₹998.40. Based on fundamentals like P/E (0.00), ROE (-12.49%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Astec Lifesciences Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹628.25. 2) Fundamental Deterioration - Declining ROE (currently -12.49%), increasing debt (D/E: 2.36), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Astec Lifesciences Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.